Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T22:13:13.077Z.
Calculation as of: 2026-10-06T22:13:13.077Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bd9bff75293b0061b415f76424971e71050022ba1ca13a61eeb09eda3fdb1614
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Rapport Therapeutics, Inc. Common Stock
Market Cap
$1.49B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.48B
Operating Cash Flow Yield
4.65%
TTM Avg
4.61%
3Y Avg
7.58%
5Y Avg
6.65%
Market Cap
$1.50B
Operating Cash Flow Yield
1.01%
TTM Avg
2.65%
3Y Avg
3.31%
5Y Avg
3.43%
Market Cap
$1.50B
Operating Cash Flow Yield
18.61%
TTM Avg
22.16%
3Y Avg
14.32%
5Y Avg
11.45%
Market Cap
$1.46B
Operating Cash Flow Yield
N/A
TTM Avg
14.73%
3Y Avg
14.73%
5Y Avg
14.73%
Market Cap
$1.45B
Operating Cash Flow Yield
10.84%
TTM Avg
10.55%
3Y Avg
6.87%
5Y Avg
5.24%
Market Cap
$1.54B
Operating Cash Flow Yield
12.46%
TTM Avg
11.11%
3Y Avg
11.89%
5Y Avg
16.15%
Market Cap
$1.44B
Operating Cash Flow Yield
5.75%
TTM Avg
8.38%
3Y Avg
5.38%
5Y Avg
4.20%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. Common Stock (RAPP) | $1.49B | N/A | N/A | N/A | N/A |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 4.65% | 4.61% | 7.58% | 6.65% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 1.01% | 2.65% | 3.31% | 3.43% |
| Nutex Health, Inc. (NUTX)vs › | $1.50B | 18.61% | 22.16% | 14.32% | 11.45% |
| GH Research PLC (GHRS)vs › | $1.48B | N/A | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | N/A | 14.73% | 14.73% | 14.73% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 10.84% | 10.55% | 6.87% | 5.24% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 12.46% | 11.11% | 11.89% | 16.15% |
| Certara, Inc. (CERT)vs › | $1.44B | 5.75% | 8.38% | 5.38% | 4.20% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | N/A | 1.93% | 1.93% | 1.93% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
